We are live on ! Find out more
CAL

Capital Analysts LLC Portfolio holdings

AUM $4.34B
1-Year Est. Return 17.55%
This Fund
S&P 500
This Quarter Est. Return
+6.93%
1 Year Est. Return
+17.55%
3 Year Est. Return
+51.26%
5 Year Est. Return
+53.67%
10 Year Est. Return
+184.17%
AUM
$1.65B
AUM Growth
+$124M
Cap. Flow
+$30.2M
Cap. Flow %
1.83%
Top 10 Hldgs %
37.71%
Holding
1,050
New
69
Increased
434
Reduced
205
Closed
52

Sector Composition

Rank Sector Weight
1 Technology 7.65%
2 Financials 4.93%
3 Healthcare 4.68%
4 Industrials 2.9%
5 Consumer Discretionary 2.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VBR icon
276
Vanguard Morningstar Small-Cap Value ETF
VBR
$38.1B
$454K 0.03%
2,536
+843
+50% +$150K
AR icon
277
Antero Resources
AR
$10.7B
$447K 0.03%
25,541
+1,214
+5% +$23K
GWX icon
278
State Street SPDR S&P International Small Cap ETF
GWX
$913M
$429K 0.03%
11,350
+5,475
+93% +$210K
ALC icon
279
Alcon
ALC
$35B
$415K 0.03%
4,681
+120
+3% +$9.88K
INTC icon
280
Intel
INTC
$513B
$414K 0.03%
8,046
-376
-4% -$19.2K
T icon
281
AT&T
T
$163B
$407K 0.02%
21,879
-13,228
-38% -$247K
SPYD icon
282
State Street SPDR Portfolio S&P 500 High Dividend ETF
SPYD
$7.71B
$399K 0.02%
9,494
+2,702
+40% +$110K
IDXX icon
283
Idexx Laboratories
IDXX
$46.2B
$396K 0.02%
601
-15
-2% -$9.42K
NKE icon
284
Nike
NKE
$61.9B
$392K 0.02%
2,353
+72
+3% +$11.9K
MASI
285
DELISTED
Masimo
MASI
$391K 0.02%
1,335
DGRE icon
286
WisdomTree Trust WisdomTree Emerging Markets Quality Dividend Growth Fund
DGRE
$146M
$390K 0.02%
13,750
-111
-0.8% -$3.12K
NVS icon
287
Novartis
NVS
$297B
$389K 0.02%
4,445
-60
-1% -$4.98K
AXP icon
288
American Express
AXP
$230B
$384K 0.02%
2,346
+103
+5% +$17.6K
RWL icon
289
Invesco S&P 500 Revenue ETF
RWL
$9.9B
$384K 0.02%
4,800
+200
+4% +$15.4K
FTCS icon
290
First Trust Capital Strength ETF
FTCS
$7.95B
$376K 0.02%
4,450
-400
-8% -$32.1K
TXN icon
291
Texas Instruments
TXN
$261B
$367K 0.02%
1,944
+154
+9% +$29.6K
ACWV icon
292
iShares MSCI Global Min Vol Factor ETF
ACWV
$3.38B
$364K 0.02%
3,364
+10
+0.3% +$1.06K
VWO icon
293
Vanguard FTSE Emerging Markets ETF
VWO
$126B
$364K 0.02%
7,372
+86
+1% +$4.34K
AMGN icon
294
Amgen
AMGN
$222B
$363K 0.02%
1,614
-98
-6% -$20.7K
BAX icon
295
Baxter International
BAX
$14.2B
$363K 0.02%
4,227
+607
+17% +$48.9K
SHOP icon
296
Shopify
SHOP
$195B
$358K 0.02%
2,600
CARR icon
297
Carrier Global
CARR
$52.8B
$345K 0.02%
6,366
-352
-5% -$19K
CI icon
298
Cigna
CI
$74.6B
$343K 0.02%
1,495
+5
+0.3% +$1.06K
ESGD icon
299
iShares ESG Aware MSCI EAFE ETF
ESGD
$12.3B
$342K 0.02%
4,298
+99
+2% +$7.88K
PH icon
300
Parker-Hannifin
PH
$135B
$331K 0.02%
1,041
+75
+8% +$23.2K

Similar funds

Capital Analysts LLC's Q4 2021 Portfolio in Review

As of Q4 2021, Capital Analysts LLC held 1,050 positions worth $1.65B, up 8.1% from $1.52B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Capital Analysts LLC's Q4 2021 filing shows 69 new, 434 increased, 205 reduced and 52 closed positions. Its largest new stake was Global X Lithium & Battery Tech ETF: 25,490 shares worth $2.15M. The largest sale was iShares MSCI USA Value Factor ETF, an estimated $3.11M.

By sector, the portfolio is most concentrated in Technology at 7.6% of assets, up from 7.1% a quarter earlier, followed by Financials and Healthcare.

  • Capital Analysts LLC's largest Q4 2021 buy was Global X Lithium & Battery Tech ETF: 25,490 shares worth $2.15M.
  • Capital Analysts LLC added most to iShares Frontier and Select EM ETF in Q4 2021, an estimated $3.58M increase.
  • Capital Analysts LLC's biggest Q4 2021 reduction was iShares Core MSCI Emerging Markets ETF, cutting an estimated $1.76M.
  • Capital Analysts LLC fully exited iShares MSCI USA Value Factor ETF in Q4 2021, selling an estimated $3.11M.
  • Capital Analysts LLC's ten largest holdings make up 38% of its $1.65B portfolio in Q4 2021.
  • Capital Analysts LLC opened 69 new positions and closed 52 in Q4 2021.
  • Capital Analysts LLC's portfolio value rose 8.1% quarter-over-quarter to $1.65B.

Based on Capital Analysts LLC's 13F filing for Q4 2021, filed 10 Feb 2022.